|
| Hire Announces FDA Approval Of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets For The Treatment Of ADHD ... |
4 Sep 09, 12:15 |
|
| Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. |
| more |
|
